Abstract : This chapter highlights various processing methodologies that may be utilized to create a variety of structural forms from the protein fi broin, which is derived from the Bombyx mori silkworm cocoon. Modulation of fi broin material properties will be considered with respect to induced protein secondary structure formation. Additional considerations will be explored for sericin removal and fi broin extraction. A review of recent scaffold processing techniques will be reported, which include materials such as native fi bers, electrospun fi bers, sponge scaffolds, hydrogels, and microspheres. Finally, a perspective on the future trends relating to fi broin protein based technologies will be discussed.
Introduction
The use of silk is ubiquitous in society as one of the most useful and oldest natural fi bers in the world with an evolutionary history of over 380 million years (Shear et al ., 1989) . Similar to how humans use concrete, metals, and plastics to build the world around us, arthropods have employed nearly 40 000 different silk proteins to produce varying structures such as webbing, nests, cocoons, and underwater air sacks (Kaplan, 1994) . Historically, humans have harnessed the fi bers produced by the domesticated Bombyx mori silkworm for uses in textile applications due to the extraordinary mechanical and visually appealing properties of the material (Shao and Vollrath, 2002) . Commercial grade silk fi bers are derived from the mulberry leaf-fed, domesticated B. mori silkworm cocoon, which is formed during the pupae phase of its life cycle (Jin et al ., 2002; Valluzzi et al ., 2002) . The Bombyx mori silkworm cocoon is composed primarily of three proteins, which consist of the glue-like glycoprotein sericin and heavy and light chains of the structural fi brous protein fi broin (Kaplan, 1994) . It has been shown that fi broin may be resolubilized into an aqueous solution, and then formed into a number of different geometrical forms Jin et al., 2002 Kim et al., 2012; Schneider et al., 2009; Soffer et al., 2008; Sukigara et al., 2003; Wharram et al., 2010; Zhang et al., 2012 Films Thin sheets of isotropic material with highly controlled length, width, and thickness dimensions Silk solution is cast upon a molding substrate and water is evaporated to grow a continuous fi lm structure
Cell culture substrates, corneal tissue, optics, sensors, electrical insulator, drug stabilization, nerve regeneration, tube formation Bray et al., 2012; Horan et al., 2005; Hwang et al., 2012; Lawrence et al., 2008; Minoura et al. , 1995; Rogers et al., 2012; Zhang et al., 2012 (Continued) Liu et al., 2012; Mandal et al., 2012; Nazarov et al., 2004; Papenburg et al., 2009; Swinerd et al., 2007; Wang et al., 2008; Lammel et al., 2010; Wang et al., 2007 Wang et al., , 2010 Wenk 2008; Wenk et al., 2011 Property of Elsevier Rockwood et al ., 2011) (Table 3 .1). This silk solution is termed 'regenerated' silk to indicate the natural origins of the fi ber, which has subsequently been processed to produce a formable biopolymer solution (Altman et al ., 2002) . It is well documented that regenerated B. mori derived silk is highly biocompatible within the body, and also demonstrates an impressive range of material properties based on a variety of processing protocols Minoura et al ., 1995; Omenetto and Kaplan, 2010; Vepari and Kaplan, 2007) . To that end, over the last two decades numerous investigators have been devoted to further understanding the potential of regenerated silk fi broin solution for use in biomedical applications in relation to tissue engineering, regenerative medicine, and drug delivery applications, which will be the focus of this chapter.
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Modulation of silk biomaterial properties
Regenerated silk fi broin solution is produced by dissolving silk cocoons into water through the use of chaotropic agents, such as heavy salts, to disrupt the high degree of hydrogen bonding that exists between the individual protein molecules Keten et al ., 2010) . The regenerated silk solution can then be reformed into a variety of three-dimensional geometries (Rockwood et al ., 2011) . Silk fi broin has previously been described as an engineering grade biopolymer due to the degree of control over its protein secondary structure formation (Lawrence et al ., 2008b) . Fibroin offers great potential for use in medically related applications due to the high degree of biocompatibility and non-infl ammatory properties when implanted within the body (Meinel et al ., 2005; Panilaitis et al ., 2003; Wang et al ., 2008b) . This chapter will explore various aspects of the material properties of silk fi broin and the multitude of applications this protein has found in biomedical related applications. Recent work has shown that constructs formed from silk solution are biocompatible in vivo , and have proven to be both non-infl ammatory and nonimmunogenic upon implantation within the body (Etienne et al ., 2009; Fini et al ., 2005; Huang et al ., 2012; Mandal et al ., 2012; Meinel et al ., 2005; Pra et al ., 2005) . Current animal trials are underway to assess the use of silk solution in the creation of scaffolds for bone, ligament, and nervous tissue Wang et al ., 2006; Yang et al ., 2011) . In addition, a number of scaffolds are being developed as in vitro tissue analogs for corneal, intervertebral disc, cardiac, breast, skin, and articular cartilage (Altman et al ., 2010; Etienne et al ., 2009; Harkin et al ., 2011; Lawrence et al ., 2009; Park et al ., 2012; Patra et al ., 2012; Yan et al ., 2012) . As with traditional tissue engineering approaches, the silk scaffolds are typically seeded in vitro with a specifi c cell type, and then cultured over time to produce tissue analogs . It has been shown that the silk fi broin protein can be degraded through a number of naturally occurring proteolytic enzymes (Horan et al ., 2005; Li et al ., 2003) . The hydrolyzed silk protein is believed to be cleared from the tissue through cellular phagocytic pathways (Desjardins, 2005) . Silk fi broin protein is primarily composed of glycine and alanine amino acids that can be reused for new protein synthesis post-degradation (Kaplan, 1994) . As a result, silk degradation products do not collect in the local environment to cause an induced infl ammatory response, which is commonly associated with other synthetic biomaterials like poly-(lactic-co-glycolic acid) (PLGA) (Onuki and Bhardwaj, 2008) .
The degradation rate and by-product formation of silk fi broin is directly related to the secondary structure content of the protein (Chen et al ., 2001; Hu et al ., 2006 Hu et al ., , 2011 Mo et al ., 2006) . By increasing or decreasing the presence of these structures the silk degradation rate can be adjusted from minutes to years (Kim et al ., 2010; Wang et al ., 2008b) . This signifi cant range of material processing is a key attribute of fi broin protein and is one of the important reasons for the potentially broad application to biomedical applications. The ability to control silk material properties offers a number of advantages over other biopolymer systems like collagen, chitosan, and alginate. The formation of silk structures begins with fi broin proteins aggregating into protein globules in solution Keten et al ., 2010; K ö nig and Kilbinger, 2007 ). The fi broin globules then aggregate to form larger bulk macromolecular structures that can then be modifi ed through a variety of processing methods . The silk material properties can then be controlled through inducing protein secondary structure formations, such as alpha-helices and beta-sheets, through a variety of post-processing techniques (Chen et al ., 2001; Hu et al ., 2006 Hu et al ., , 2011 Mo et al ., 2006) ( Fig. 3.1 ) .
The formation and organization of these structures modulates the total hydrogen and hydrostatic bonding within the bulk structure of the material, which affects the material properties at the macroscale . A variety of silk processing methods have been developed to produce a multitude of structures, and range from the use of physical factors, such as mechanical stress and heat, to the use of chemicals, from water to organic solvents, in order to induce controlled secondary structure formation (Agarwal et al ., 1997; Gupta et al ., 2007; Jin et al ., 2005; Lu et al ., 2010; Mandal et al ., 2012) . As a result, fi broin material properties such as degradation rate, hydrophobicity/hydrophilicity, transparency, mechanical strength, porosity, oxygen permeability, and thermal stability may be altered (Agarwal et al ., 1997; Horan et al ., 2005; Jin et al ., 2004b; Kim et al ., 2005; Motta et al ., 2002; Tretinnikov and Tamada, 2001) . In this regard, silk proteins can be considered as an engineering class of biopolymers in which the material properties can be defi ned for a given application.
Water plays an important role in processing regenerated silk fi broin materials. The control of regenerated silk fi broin material properties is primarily achieved through modulation of hydration state (Agarwal et al ., 1997; Hu et al ., 2011; Lawrence et al ., 2010; Motta et al ., 2002; Sohn et al ., 2004) . Water acts as a lubricant, which allows for protein chain movement and secondary structure formation (Hu et al ., 2007 (Hu et al ., , 2008 (Hu et al ., , 2011 . As a result, processing of regenerated silk materials can be achieved through aqueous based processes, however, organic solvents can be utilized as well (Chen et al ., 2001; Hu et al ., 2011; Mandal et al ., 2012) . The use of water vapor to control protein secondary structure formation is commonly referred to as water-annealing (Hu et al ., 2011; Jin et al ., 2005) . The extent of secondary structure modifi cation is controlled through enhancing water vapor content available for interaction with the fi broin protein chains (Hu et al ., 2007; Lawrence et al ., 2008b; Mo et al ., 2006) . With more extensive secondary structure formation there is an increase in internal hydrogen bonding which modulates the apparent material properties, which may be specifi ed for a given application (Hu et al ., 2008) .
Previous research indicates that beta-sheet content can be modulated between 10% and 60% of total protein secondary structure through various water-annealing processes (Lawrence et al ., 2008b) . For example, placing newly cast silk fi lms in a chamber with water placed in the basin to increase chamber humidity will cause the formation of up to 24% beta-sheet content, however if this is used in conjunction with high pressure and temperature steam, the beta-sheet formation will increase to 60% (Lawrence et al ., 2008b) . Further work has demonstrated that exposing the silk material to increasing water vapor content will drop the glass transition temperature ( T g ) from 180 to 40°C (Agarwal et al ., 1997; Hu et al ., 2006 Hu et al ., , 2011 . Practical applications of this drop in T g have been utilized to produce rapid surface imprinting methods and also for modifying silk scaffold degradation in vitro and in vivo Arai et al ., 2004; Wang et al ., 2008b) . These specifi c examples provide compelling evidence for the large range of material processing windows attainable for controlling fi broin protein secondary structure formation.
Silk fibroin materials and their use in biomedical applications
The silk fi broin protein is a structuring molecule that has the ability to be processed into numerous forms through a variety of techniques. Due to the material's inherent biocompatibility, the protein has been recently utilized as a scaffold for developing a number of biomedical product ideas for use in clinical applications. A few examples of such clinical applications are explored below.
Sericin extraction and fi broin solubilization
Silk fi bers were traditionally used as medical sutures before the development of biodegradable synthetic polymers . However, silk sutures would in many cases need to be removed due to their slow biodegradation rate and the potential for infl ammatory reactions to their presence . This infl ammation was largely found to be a reaction to the presence of the glycoprotein sericin fi ber coating, which could be removed through cleaning the fi bers with detergents (Barker, 1975; Santin et al ., 1999) . Once the sericin was removed the regenerated structural silk fi broin protein was well tolerated by the body (Meinel et al ., 2005; Panilaitis et al ., 2003; Santin et al ., 1999; Wang et al ., 2008b) . As a result both native silk fi bers free of sericin and regenerated fi broin protein solution offer desirable material properties for designing silk-based biomedical devices. Silk fi broin solubilization has been documented since the beginning of the twentieth century (Matthews, 1913) , but only recently has the use of regenerated silk solution for biomedical applications been studied (Altman et al ., 2002; Minoura et al ., 1995) . The most ubiquitous method to produce regenerated silk fi broin solution is through the use of NaCO 3 and heavy salts like LiBr (Lawrence et al ., 2012b; Rockwood et al ., 2011) ( Fig. 3.2 ) . In addition, mixtures with urea and ionic liquid solutions have been used to produce silk solution (Gupta et al ., 2007; Shaw, 1964) ; these processes will not be described here, however, for brevity.
Silk fi bers may be cleaned of contaminating sericin proteins by boiling cocoons or fi bers in 0.02M NaCO 3 in less than 1 h. The extracted fi bers should be thoroughly rinsed with pure water, and then allowed to dry using clean convective air. The dried fi bers can then be dissolved using a 9.3M LiBr solution to disrupt hydrogen bonding between the fi broin protein chains (Lawrence et al ., 2012b) . The solution should then be allowed to thoroughly dissolve for up to 4 h at 60°C to ensure complete dissolution, while making sure the reaction container is covered to prevent water evaporation. The heavy salts, in this case LiBr, can then be removed from the silk solution through dialysis against pure water over a period of 48 h. Typically the molecular weight cut-off for the dialysis membrane is 3500 Da, which is permeable enough to allow for the LiBr salts and water to travel freely while retaining the 25 and 390 kDa fi broin light and heavy protein chains, respectively (Kaplan, 1994) . Final silk solution concentrations range from 6% to 10% wt./vol. content, however dialysis against high molecular weight water-soluble polymers, like polyethylene glycol (PEG), allow for concentrations of the silk solution of over 20% wt./vol. Mandal et al ., 2012; Nazarov et al ., 2004) . The silk solution can then be stored in a 4°C refrigerated environment, where the material has shown stability for up to two months post production (Le et al ., 2008; Matsumoto and Lindsay, 2008) .
Native fi bers
Native silk fi bers derived from the B. mori silkworm cocoon provide the raw material that is used to produce regenerated silk solution. Silk fi bers have found wide utility in the medical world as sutures over the past millennia . As mentioned earlier these fi bers are composed of the fi broin protein, which provides robust mechanical strength in the native silkworm cocoon. Recently, the utility of 'extracting' the native fi ber from the sericin coating proteins has been invaluable for the use of this protein in medical applications . The extracted silk fi bers have relatively high tensile strength recorded between 500 and 740 MPa, a modulus between 5 and 17 GPa, and an elongation to break ranging from 4% to 20% . This is in the order of 5-10 times higher when compared to other synthetic and natural polymers. Native silk fi bers can then be further used for the design of medical devices.
Recently, silk fi broin native fi bers have been combined to produce scaffolding structures that have found utility in soft tissue repair, such as ligaments (Altman et al ., 2002; Vunjak-Novakovic et al ., 2004) . Specifi cally a silk fi ber mesh can be twisted together to produce a rope structure that mimics the natural mechanics of the anterior cruciate ligament (ACL) (Altman et al ., 2002) . The structure can then be implanted in vivo to serve as a scaffold to regenerate new ligament tissue (Vunjak-Novakovic et al ., 2004) . Extending from this work these fi bers can then be resolubilized into regenerated silk solution as described above to produce a number of geometrical structures, which are described further below.
Electrospun fi bers
Electrospinning silk solution is a favored processing methodology for producing nanometer-to micron-scale fi bers that result in a high degree of available surface area for use in creating scaffolds for tissue engineering and regenerative medicine purposes (Jin et al ., 2002) . In brief, electrospun materials are produced by applying a strong electric fi eld between a polymer solution and a collection device (Soffer et al ., 2008) . In the case of silk fi broin this has been readily accomplished using both organic solvents and aqueous based processes (Jin et al ., 2002; Sukigara et al ., 2003) . The electrospun silk fi bers have found utility in producing scaffolds for a variety of biological applications such as growing cardiac, bone, nerve, and skin tissue (Jin et al ., 2004a; Schneider et al ., 2009; Soffer et al ., 2008; Wharram et al ., 2010; Zhang et al ., 2012b) .
One area of work has focused on the use of a silk fi broin and poly-(ethylene oxide) (PEO) solution blend that reduces material brittleness and enables ready processing and handling of the fi nal material (Jin et al ., 2002) . Fiber diameters range between 700 and 900 nm for varying silk/PEO blends. Further work using silk/PEO blends was undertaken to form electrospun mats for use in culturing human bone marrow stromal cells (hBMSCs), which demonstrated excellent cell attachment, spreading, and culture growth over a 14-day period (Jin et al ., 2004a) . These materials compared favorably with native silk fi ber controls. Building from this work silk/PEO electrospun fi bers were used to produce tubular scaffolds for use as smalldiameter vascular grafts (Soffer et al ., 2008) . Human endothelial and smooth muscle cells were successfully grown on these scaffolds, and mechanical testing demonstrated the ability of the constructs to withstand arterial pressures and tensile properties comparable to native vessels (Soffer, 2006) . Similar blended silk/PEO electrospun constructs were developed for use in wound healing applications Wharram et al ., 2010) . Initial material characterization proved that these scaffolds exhibited aqueous absorption, water vapor transmission, oxygen permeation, and enzymatic biodegradation profi les applicable for full thickness wound site regeneration . Further studies used a human skinequivalent wound healing model to demonstrate physiological feasibility ). The study showed that the silk/PEO electrospun fi bers could be loaded with epidermal growth factor (EGF) and release 25% of the molecule content over a one-week period. It was shown that the electrospun mats increased wound closure by a remarkable rate, increased by 90% when compared to controls. Additional work has shown successful implantation of electrospun silk fi broin constructs in vivo using a subdermal rat model . Results indicated that electrospun constructs demonstrated varying biodegradation profi les based on post-processing with varying blends of ethanol and propanol concentrations, where higher ethanol concentrations showed longer degradation times. In addition, implanted constructs proved highly biocompatible, and supported cell infi ltration for materials treated with lower ethanol concentrations. Together these fi ndings suggest promise for such materials in the use of chronic wound healing.
Silk fi broin fi lms
Silk fi lms offer an elegant and straightforward biomaterial of choice for medical device design. Due to the inherently less complex nature of fi lms these materials offer rapid characterization and design with regards to scaffold development. The dynamic protein secondary structure of the fi broin beta-sheet and alpha-helical structures has been largely determined from studies utilizing silk fi lm samples (Hu et al ., 2008; Motta et al ., 2002; Tretinnikov and Tamada, 2001) , and they possess the longest history of scientifi c experimentation and use (Matthews, 1913; Minoura et al ., 1990) . As a result, silk fi lms offer the most immediate potential utility for a variety of biomedical applications (Kaplan and Omenetto, 2012b; Omenetto and Kaplan, 2008) . As a biomaterial of choice they offer a number of advantages for in vitro characterization due their ease of production and consistent material properties (Lawrence et al ., 2012b; Rockwood et al ., 2011) . Silk fi lm material properties like biodegradation, mechanical properties, chemistry, and optical properties may be readily modulated for a desired application (Arai et al ., 2004; Horan et al ., 2005; Karageorgiou and Meinel, 2004; Lawrence et al ., 2008a; Li et al ., 2003; Motta et al ., 2002) . In addition, fi broin fi lms have been shown to support a multitude of cell types including a variety of cell lines from epithelium, endothelium, and fi broblasts, which allows for the adaptation to a variety of tissue systems (Arai et al ., 2004; Meinel et al ., 2005; Panilaitis et al ., 2003) . In vitro results can be quickly translated to in vivo models due to the fi broin fi lm possessing a high level of biocompatibility and material consistency (Arai et al ., 2004; Meinel et al ., 2005; Panilaitis et al ., 2003) .
A recent interest has been the use of patterned silk fi lms to develop a multitude of silk scaffolds and devices (Gil et al ., 2010; Kaplan and Omenetto, 2012a; Lawrence et al ., 2008a Lawrence et al ., , 2009 Kaplan, 2008, 2010; Rogers et al ., 2012; Tsioris et al ., 2011) . A nanopatterned fi broin fi lm surface may be produced by casting silk solution upon a molding surface, then allowing the water to evaporate to form a fi lm, following which the dried silk fi lm is air-lifted from the molding surface (Lawrence et al ., 2008a; Omenetto and Kaplan, 2008; Perry et al ., 2008) . In addition, the water-annealing technique may be employed post-casting to produce water insoluble fi lms through the induction of alpha-helical and beta-sheet secondary structure formations for use in biological applications (Lawrence et al ., 2008a; Rockwood et al ., 2011) .
This technique has been recently used to produce culture surfaces for investigating corneal cell response to silk fi lm surface topography (Gil et al ., 2010; Lawrence et al ., 2009 Lawrence et al ., , 2012a . Results indicated that silk fi lm surface topography could be used to direct corneal epithelial and fi broblast alignment (Gil et al ., 2010; Lawrence et al ., 2009) , and that the edge surface of the patterned topography signifi cantly infl uenced localization of focal adhesion formations . One immediate biomedical application for silk fi lms is for use in repairing the cornea after injury due to their transparent nature and high degree of biocompatibility (Bray et al ., 2011; Chirila et al ., 2008; Liu et al ., 2012a) .
In addition to the surface patterning capabilities of silk fi broin, the material can also be employed for immobilizing bioactive compounds for later use without loss of activity or function (Demura and Asakura, 1989; Lawrence et al ., 2008a; Liu et al ., 1996; Numata and Kaplan, 2010; Tsioris et al ., 2011; Zhang et al ., 2012a) . Recent work has demonstrated that the antibiotic tetracycline and the measles, mumps, and rubella vaccine can be successfully stored within a dried silk fi broin fi lm matrix for six months at 60°C (Zhang et al ., 2012a) . Such capability eliminates the need for cold storage and may revolutionize the way many labile molecules are stored and utilized throughout the world (Zhang et al ., 2012a) . In addition, the molecule immobilization work has been combined with the unique surface patterning properties of silk to produce a microneedle delivery system: high aspect ratio topographic features were produced on a silk fi lm surface that were strong and sharp enough to pierce the skin (Tsioris et al ., 2011) . The fi broin protein secondary structure is then modifi ed to release a therapeutic molecule in a continual release profi le after the microneedles are embedded within the hydrated dermis.
Silk fi lms have also found utility as carrier surfaces for use in biomedical applications. Recently it has been shown that electronic components may be fabricated upon fi broin fi lm surfaces that can later fully integrate or degrade naturally with the surrounding environment (Hwang et al ., 2012) . Silk fi broin has been shown to be an optimal insulating material of choice in which semiconductor materials, like silicon, can be readily integrated to produce biodegradable and highly functional electronic components (Hwang et al ., 2012; Kim et al ., 2010; Tao et al ., 2012) . The fi broin fi lms can be processed to allow for a conformational adhesion to a given surface such as on brain, bone, and food surfaces (Hwang et al ., 2012; Kim et al ., 2010; Tao et al ., 2012) . Recent work has demonstrated the feasibility of mapping the feline neural brain surface using sensors that utilize the insulator and carrier abilities of silk fi broin (Kim et al ., 2010) . Similar efforts have utilized such conformable electronics to adhere to food products to determine spoilage or bacterial contamination ). These studies demonstrate the utility of silk fi broin as a manufacturing material in which continued development will provide a sustainable, biodegradable material platform that can be used for a number of high-tech, medicinal, and environmental applications (Kaplan and Omenetto, 2012b) .
Sponge scaffolds
Regenerated silk fi broin solution may also be processed to produce threedimensional sponge scaffolds for use in tissue engineering Nazarov et al ., 2004) . Sponge scaffolds provide a framework of interconnected pores with a high amount of surface area within a defi ned threedimensional volume, which allows for cell attachment and tissue ingrowth. Initial studies indicate that the porosity and mechanical properties of these scaffolds can be readily controlled through salt leaching and gas foaming processes (Nazarov et al ., 2004) . Pores averaged 100 μ m for both processing conditions, and reached porosity void volume ranges between 84% and 98%. However, compressive strength measured up to 175 kPa for salt leached scaffolds, and up to 280 kPa for gas foamed structures. Further work identifi ed that silk fi broin concentration was a critical determinant of fi nal porosity formation and mechanical properties (Yan et al ., 2012) . Specifi cally, porosity could be dialed in from 80% to 90% by ranging the fi broin concentration between 8% and 16%, respectively. Such scaffolds could fi nd utility in the production of cartilage, bone, or connective tissue engineering applications.
Additional methods to produce silk scaffolds utilize sacrifi cial template techniques (Swinerd et al ., 2007) . It has also been shown that silk fi broin solution can be mixed with 500 nm diameter polystyrene beads and then dried to form a solid structure. The dried construct is then treated with methanol to produce the highly stable silk beta-sheet protein secondary structure. The scaffold is then treated with toluene to leach out the polystyrene beads. What is left is a spongy scaffold with 400 nm pores interspersed throughout the scaffold, and could elastically recover from 112 MPa compressive loads while possessing super hydrophobicity properties that may not be desirable for in vivo use (Swinerd et al ., 2007) .
Follow up in vivo work to assess silk fi broin sponge scaffold biocompatibility was undertaken in rat muscle pockets and subcutaneous animal models (Wang et al ., 2008b) . Results indicated that the implanted scaffolds were highly biocompatible and encouraged tissue ingrowth to varying extents depending on porosity and solvent processing conditions (i.e., aqueous or organic solvent) (Wang et al ., 2008b) . It was shown that all aqueous processed scaffolds degraded within a 2-6-month time frame, while scaffolds prepared using the organic solvent hexafl uoroisopropanol (HFIP) persisted beyond one year post-implantation (Wang et al ., 2008b) .
Following on from this work, scaffolds were produced that had high compressive strength characteristics of up to 13 MPa within a hydrated environment, which could allow for functional bone formation . These scaffolds utilized a novel processing method in which silk fi bers were combined with NaOH pellets in water to produce a spongelike scaffold construct. Subcutaneous in vivo studies in rats demonstrated a high degree of biocompatibility and neovascularization throughout the scaffold. In addition, the standard sponge scaffolding processing techniques can also be combined with other innovative methods. Silk fi broin was combined with gelatin, dried, and then freeze dried to produce a sponge scaffold matrix upon a molding template surface (Liu et al ., 2012b) . The template was designed to mimic the liver by producing a scaffold with grooves and substructures patterned on the surface. The scaffolds were then seeded with primary hepatocyte cultures and, after seeding, the sponge layer was rolled upon itself to form a three-dimensional structure (Liu et al ., 2012b; Papenburg et al ., 2009) . Analysis of the structures revealed the scaffolds were highly biocompatible and encouraged tissue growth. Future processing techniques will continue to evolve for producing silk fi broin sponge scaffolds for a variety of applied tissue engineering applications.
Hydrogels
Hydrogels offer a tissue culture system where interconnected fi laments aggregate and stabilize water within a confi ned volume to produce a gel. Gelation of the silk fi broin solution can be controlled by temperature, calcium ion concentration, pH, and polymer blending with materials like PEO to produce a hydrogel (Kim et al ., 2004) . Results indicated that gelation time decreased with an increase in protein concentration, decrease in pH, increase in temperature, addition of calcium, and addition of PEO. Gelation was linked to beta-sheet secondary structure formation throughout the hydrogel structure (Kim et al ., 2004; Matsumoto et al ., 2006) . It was shown that above 15% beta-sheet content gelation time increased linearly with fi broin protein concentration in solution (Matsumoto et al ., 2006) . Such results indicate that silk fi broin hydrogels offer a number of control points for defi ning material properties.
Building upon this work, the silk fi broin gelation rate was highly controlled through the use of sonication (Wang et al ., 2008a) . Gelation can be induced from minutes to hours depending on sonication parameters, such as power output and time, and silk fi broin concentration. Interestingly, the sonicated silk solution had human mesenchymal stem cells (hMSCs) added while in the solution state, which then encapsulated the cells within the hydrogel matrix. The cells were found to grow and proliferate within the gel over a 21-day time period, where cell viability was highest for lower silk fi broin concentration gels. A subsequent in vivo study implanted silk fi broin hydrogels subcutaneously within nude mice (Etienne et al ., 2009) . Results indicated that human fi broblasts embedded within the material had a 68% survival rate after 12 weeks post-implantation. Revascularization had occurred and no infl ammatory response was observed after the 3-month implantation period. These hydrogel materials are anticipated to have uses in periodontal, maxillofacial, and dermal fi lling applications.
Microspheres
Microspheres describe a general class of particulates that have diameters in the high nanometer to micron range and assume a spherical shape, which can be used for a variety of biomedical purposes such as controlled drug release applications. Silk microspheres can be readily produced by mixing regenerated fi broin solution with lipid vesicles that act as templates to effi ciently load biological molecules in an active form for sustained release (Wang et al ., 2007b) . The lipid could then be subsequently removed by methanol or sodium chloride treatments that produced silk fi broin microspheres with beta-sheet structure, and measured 2 μ m in diameter on average. Studies were then undertaken using horseradish peroxidase (HRP) as a model therapeutic molecule that was encapsulated within the silk microspheres using freeze-thaw cycles that showed enzymatic activity post encapsulation and continually released over a two-week time frame (Wang et al ., 2007a (Wang et al ., , 2007b . Additionally, silk microspheres could be produced by using a fi broin and polyvinyl alcohol blend methodology to avoid the complications from the freeze-thaw cycle and use of organic solvents . Fibroin/ PVA blended fi lms were fi rst produced by drying the solution into fi lm form, the dried fi lm was then rehydrated in water, and residual PVA was removed by centrifugation. Controlled microsphere diameters ranging from 300 nm up to 20 μ m were achieved.
An additional processing method was developed in which drug-loaded silk fi broin microspheres were produced using a laminar jet break-up of aqueous solution (Breslauer et al ., 2010; Wen et al ., 2011; Wenk et al ., 2008) . Sphere diameters ranging between 100 and 440 μ m were produced depending on the diameter of the nozzle and treatment to induce water insolubility using either methanol or water annealing methods (Jin et al ., 2005; Wenk et al ., 2008) . Insulin-like growth factor (IGF) was used as a model drug for delivery characterization, and showed a seven-week delivery period. In vitro results indicate that silk microspheres are highly biocompatible, and released IGF increased MG-63 cell line growth over time (Wenk et al ., 2008) . Additionally, smaller sphere sizes ranging in the hundreds of nanometers to the lower micron size range can be similarly controlled through the use of salting-out techniques of potassium phosphate solutions (Lammel et al ., 2010) . Silk fi broin microspheres may offer much promise for drug delivery applications for a variety of applications, and future in vivo studies will further aid in promoting their translation to clinical use.
Conclusion and future trends
The functionality of silk fi broin in the production of biomedical structures is only limited to the variety of ways to controllably process the varying properties of the material. As with most silk proteins, the highly modifi able secondary structure of fi broin in solution can be manipulated to form any variety of three-dimensional structures (Rockwood et al ., 2011) . In addition, use of fi broin as a biomaterial post-sericin extraction is well documented and therefore will continue to fi nd itself as a material of choice for biomedical applications Vepari and Kaplan, 2007) . Future developments of silk fi broin based scaffolds will benefi t from further studies focused on improving material properties and assessing these materials in vivo. In addition, promising work utilizing composite methodologies is being undertaken that has shown much progress in producing fi broin devices for use in peripheral nerve and intervertebral disc regeneration (Ghaznavi et al ., 2011; Nectow et al ., 2012; Park et al ., 2012) . Progress will continue in utilizing silk for in situ sensors and electronics for monitoring a variety of medical conditions (Hwang et al ., 2012; Kim et al ., 2010) . Although 40 000 other varieties of silk proteins exist, no other is as highly produced or ubiquitously utilized as silk fi broin derived from the domesticated B. mori silkworm (Shear et al ., 1989) . As the world continues to look for alternatives to synthetic based polymers, fi broin may be a hopeful candidate for the future development of biologically based building materials for medical applications and beyond.
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